The use of molecular genetics in the differential diagnosis of renal tumors
Authors:
Jindřich Branžovský 1; Petr Martínek 1; Kevin Baulet 1; Ivan Trávníček 2; Petr Stránský 2; Tomáš Vaneček 1; Milan Hora 2; Ondřej Hes 1
Authors place of work:
Šiklův patologicko-anatomický ústav LF UK a FN, Plzeň
1; Urologická klinika LF UK a FN, Plzeň
2
Published in the journal:
Ces Urol 2012; 16(4): 214-221
Category:
Review article
Summary
Renal tumors are a highly heterogenous group of tumors which makes their diagnosis increasingly complicated. The use of molecular and genetic techniques has resulted not only in the improvement of classification and differential diagnosis, but has also led to a better understanding of the biological behavior of these tumors. The increasing use of targeted therapy makes precise diagnosis of each lesion important and in the future it may become a crucial tool for the selection of proper treatment.
Key words:
kidney, renal cell carcinoma, oncocytoma, translocation renal cell carcinoma, morphology, molecular biology, diagnostics, genetics, biological treatment, differential diagnostics.
Zdroje
1. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. Lyon: IARC Press 2004.
2. Allory Y, Bazille C, Vieillefond A, Molinié V, Cochand-Priollet B, Cussenot O, Callard P, Sibony M. Profiling and classification tree applied to renal epithelial tumours. Histopathology 2008; 52(2): 158–166 (Epub 2007 Nov 22).
3. Lopez-Beltran A, Montironi R, Egevad L, Caballero-Vargas MT, Scarpelli M, Kirkali Z, Cheng L. Genetic profiles in renal tumors. Int J Urol 2010; 17: 6–19.
4. Gobbo S, Eble JN, MacLennan GT, et al. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Pathol 2008; 32: 1780–1786.
5. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008; 32: 1239–1245.
6. Hora M, Hes O, Eret V, Ürge T, Klečka J, Ferda J, Chudáček Z, Vaněček T, Michal M. Translokační renální karcinom Xp11.2 typu ASPL/TFE3 (Kidney carcinoma associated with Xp11.2 translocation type ASPL/TFE3). Ces Urol 2008; 12(3): 186–193.
7. Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod Pathol 2003; 16: 1053–1059.
8. Cossu-Rocca P, Eble JN, Delahunt B, et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol 2006; 19: 488–493.
9. Brandal P, Lie AK, Bassarova A, Svindland A, Risberg B, Danielsen H, Heim S. Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas. Mod Pathol 2006; 19: 186–194.
10. Hes O, Brunelli M, Michal M, et al. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol 2006; 10: 133–139.
11. Urge T, Hes O, Ferda J, Chudáček Z, Eret V, Michal M, Brunelli M, Martignoni G, Hora M. Clinical characteristics of oncocytic papillary renal cell carcinoma, World J Urol 2010; 28(4): 513–517.
12. Brunelli M, Eble JN, Zhang S, Martignoni G, Delahunt B, Cheng L. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol 2005; 18: 161–169.
13. Crotty TB, Lawrence KM, Moertel CA, et al. Cytogenetic Analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that –Y, -1 may be a characteristic anomaly in renal oncocytomas. Cancer Gen Cytogenet 1992; 61: 61–66.
14. Brimo F, Epstein JI. Selected common diagnostic problems in urologic pathology. Perspectives from a large consult service in genitourinary pathology. Arch Pathol Lab Med 2012; 136: 360–371.
15. Brunelli M, Gobbo S, Cossu-Rocca P, Cheng L, Hes O, Delahunt B, Pea M, Bonetti F, Mina MM, Ficarra V, Chilosi M, Eble JN, Menestrina F, Martignoni G. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol 2007; 20: 303–309.
16. Dvorakova M, Dhir R, Bastacky SI, Cieply KM, Acquafondata MB, Sherer CR, Mercuri TL, Parwani AV. Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up. Diagn Pathol 2010; 5: 32.
17. Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube’ syndrome: a new series of 50 families and a review of published reports. J Med Genet 2008; 45: 321–331.
18. Mosquera JM, Dal Cin P, Mertz KD, Perner S, Davis IJ, Fisher DE, Rubin MA, Hirsch MS. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas. Diagn Mod Pathol 2011; 20(3): 129–137.
19. Zhong M, De Angelo P, Osborne L, Keane-Tarchichi M, Goldfischer M, Edelmann L, Yang Y, Linehan WM, Merino MJ, Aisner S, Hameed M. Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma. Am J Surg Pathol 2010; 34(6): 757–766.
20. Argani P, Lae M, Hutchinson B,Reuter V, Collins MH, Perentesis J, Tomaszewski JE, Brooks JS, Acs G, Bridge JA, Vargas SO, Pavis IJ, Fischer DE, Ladanyi M. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 2005; 29: 230–240.
21. Hora M, Hes O, Ürge T, Eret V, Klečka J, Michal M. A distinctive translocation carcinoma of the kidney (“rosette-like forming”, t(6;11), HMB45 positive renal tumor). Int Urol Nephrol 2009; 41(3): 553–557.
22. Petersson F, Vanecek T, Michal M, Martignoni G, Brunelli M, Halbhuber Z, Spagnolo D, Kuroda N, Yang X, Cabrero IA, Hora M, Branzovsky J, Trivunic S, Kacerovska D, Steiner P, Hes O. A distinctive translocation carcinoma of the kidney; „rosette forming,“ t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases. Hum Pathol 2012; 43: 726–736.
23. Merino MJ, Torres-Cabala C, Pinto P, Linehan WM. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 2007; 31: 1578–1585.
24. Hora M, Ürge T, Eret V, Stránský P, Klečka J jr, Kreuzberg B, Ferda J, Minčík I, Schraml J, Študent V, Michal M, Hes O. Hybridní onkocytické/chromofóbní tumory (HOChT) ledviny („Birt-Hogg-Dubé syndrome like“ tumory). Čes Urol 2010; 14(4): 237.
25. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, Brown RS. Hereditary renal- cell carcinoma associated with a chromosomal translocation. N Engl J Med 1979; 301: 592–595.
26. Kovacs G, Hoene E. Loss of der(3) in renal carcinoma cells of a patient with constitutional t(3;12). Hum Genet 1988; 78: 148–145.
27. Kovacs G, Brusa P, de Riese W. Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas. Int J Cancer 1989; 43: 422–427.
28. Au KS, Rodriguez JA, Rodriguez E Jr, Dobyns WB, Delgado MR, Northrup H. Mutations and polymorphisms in the tuberous sclerosis complex gene on chromosome 16. WHO Hum Mutat 1997; 9(1): 23–29.
Štítky
Paediatric urologist Nephrology UrologyČlánok vyšiel v časopise
Czech Urology
2012 Číslo 4
Najčítanejšie v tomto čísle
- Myoglobinuria as a manifestation of rhabdomyolysis following extreme physical exertion
- Nuclear medicine imaging of prostate cancer
- Treatment outcomes of BCG vaccine in patients with T1G3 urothelial cancer – a retrospective analysis
- Retroperitonal liposarcoma in the area of the lower pole of the kidney